Clinical trial

Efficacy of ProgenaMatrix™ in the Management of DFUs

NCT06292026

Study summary

ClinicalTrials.gov

Efficacy of ProgenaMatrix™ in the Management of DFUs

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention ProgenaMatrix Keratin graft Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention standard of care Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-03-14

PhaseNA

Conditions

Diabetic Foot Ulcerunresolved

Interventions

ProgenaMatrix Keratin graftDEVICE

standard of careOTHER

Sponsors & collaborators

ProgenaCare Global, LLClead sponsor

Mapped research locations

PuyallupWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06292026 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.